Search results for " industry"
Article
Tackling Analytical Method Development for ADCs
“Cross-fertilization within the biopharmaceutical industry, particularly driven by the proliferation of ADC-focused conferences, workshops, instrument company webinars, etc., has lead to an increased …
Article
Labeling of Biosimilars
Regulatory issues
Nonetheless, there are a number of regulatory issues with biosimilars that parts of the pharmaceutical industry believe still need to be sorted out by EMA. The biggest of these is…
Article
Implementation of Raw Material Control Strategies in the Manufacture of Single-Use Bioprocessing Containers
The use of disposable equipment in the biopharmaceutical industry is rapidly increasing, as it offers advantages in terms of flexibility, elimination of cleaning procedures, and reduced capital expend…
Article
What Drove Biopharma Development in 2014?
In fact, the monoclonal antibody market represents the fastest growing segment within the biopharmaceutical industry. The global monoclonal antibody market size exceeded $80 billion in 2013, and could…
Article
Biopharma Manufacturers Respond to Ebola Crisis
Vaccine industry executives and biotech innovators joined the discussion about conducting effective and ethical clinical trials and ramping up production of promising vaccines and therapies. A main ai…
Article
Application of Quality by Design to Viral Safety
40-47
The biotech industry has begun to implement a quality-by-design (QbD) approach to ensure the quality of biopharmaceuticals. Using this approach, products are developed with a thorough under…
Article
A Q&A With Phil Lester, co-organizer of the HTPD Conference
I thought it would be interesting to get out ahead of the curve—put together people from academics and the industry to discuss the potential of HTPD and how it could change the way we do business. I d…
Article
A Q&A With Parrish Galliher About Adopting Single-Use Systems
How will increased adoption of single-use impact the industry?
On a commercial level, it will save companies a lot of capital compared to stainless steel facilities. Since 90% of drugs fail during…
Article
Q&A with Eric Langer, about the evolution of the role of CMO’s in Bioprocessing
Read more Q&A's with Industry Leaders here.
Article
Biopharma Moves to Integrated, Single-Use, Downstream Processing
She notes that the adoption of pre-packed, limited-use chromatography in the industry has been particularly slow, even though the value proposition for early clinical phase manufacturing is clear (tim…